Our pharmaceutical R&D division is dedicated to developing innovative, highly effective, and safe cancer and antiviral drugs. We strive to alleviate patient suffering and fear, ultimately achieving complete recovery without side effects or relapse.
Our lead drug candidate, having successfully completed preclinical and Phase I clinical trials in accordance with EMA and US FDA regulations, is the focus of ongoing research and development through collaborations with global pharmaceutical companies and research institutions.
We are committed to expanding our pipeline and exploring the full therapeutic potential of our discoveries.
Stavroula Georgiou | Director
Fighting Cancer. One Life at a Time.
Welcome to Inqtel Pharmaceuticals. We're entering a new era, driven by groundbreaking research and development in cancer solutions. Our patented advancements are paving the way for global impact, bringing hope and innovative treatments to patients worldwide.
We've partnered with leading institutions to conduct collaborative studies, evaluating the effectiveness of our treatment and exploring its full therapeutic potential.
Feel free to send us your inquiry message by just completing this short form.